(1. Department of Quality Control ,Tianjin Blood Center, Tianjin 300110,China ;2.Tianjin Life Science Research Center, Tianjin Medical University, Tianjin 300070,China)
Objective: To explore the relationship between the miRNA-372/373 levels in plasma and the early-stage infection of HBV, to uncover the potential
of miRNA-372/373 in the diagnosis of the early-stage infection of HBV. Methods: Blood samples for miRNA detecting were collected from 54 donors who donated blood from 2013.3 to 2013.9 in Tianjin. All the samples were divided into 3 groups: eighteen samples were Normal; 18 samples were ELISA testing (+) and NAT (-) (HBV-S); the last 18 samples were ELISA testing (+) and NAT(+) (HBV-D). Quantization of miRNA-372 and miRNA-373 in all the 54 plasma samples were performed using quantitative RT-PCR. At last, compared thederegulated miRNA(miRNA-372/-373) in the plasma of the three groups respectively, and the expression patterns of miRNA-372 andmiRNA-373 were analyzed using statistical methods; the correlation between the expression level of miRNA-372/-373 and the copy number of HBV DNA in NAT(+) plasma was statistically analyzed. Results: Compared with the Normal, miRNA-372 and miRNA-373 in
?both HBV-S and HBV-D were up-regulated. Furthermore, both miRNA-372 and miRNA-373 were up-regulated more significantly in HBV-D than in HBV-S. Moreover, the levels of both miRNA-372 and miRNA-373 were positively correlated with the copy number of HBV DNA in HBV-D. Compared with miRNA-372, miRNA-373’s positive correlation with the copy number of HBV DNA was significantly higher. Conclusion: The correlation between miRNA-372/373 in plasma
and the early-stage Infection of HBV is high , indicating their potential values in the early-stage diagnosis of HBV infection.
[1]Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5): 843[2]Nikaki A, Piperi C, Papavassiliou A G. Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy[J]. Expert Opin Investig Drugs, 2012, 21(10): 1475
[3]Kwak M S, Lee D H, Cho Y, et al. Association of polymorphism in Pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients[J]. PLoS One, 2012, 7(7): e41983
[4]Guo H Y, Liu H Y, Mitchelson K, et al. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B[J]. Hepatology, 2011, 54(3): 808
[5]Chen C F, Ridzon D A, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR[J]. Nucleic Acids Res, 2005, 33(20): e179
[6]曾洋,刘星霞,林瑞竹,等.microRNA-373参与调控人脂肪来源间充质干细胞成骨分化[J].基础医学与临床,2012,32(2):119
[7]武卫华,孔璟,叶彬.hsa-mir-373对肿瘤细胞中E-钙黏蛋白表达的影响[J].生物技术通报,2011(8):167
[8]刘琳,王月玲,王江芬.miR-21、miR-126、miR-143和miR-373在正常宫颈组织、宫颈癌组织及Hela细胞中的表达差异[J].四川大学学报:医学版,2012,43(4):536
[1]刘利维,刘春雨. MicroRNAs 与前列腺癌的表观遗传学研究进展[J].天津医科大学学报,2014,20(01):74.
[2]王巧瑞 综述,王晓晔 审校.微小RNA在先天性巨结肠中的研究进展[J].天津医科大学学报,2021,27(04):435.
作者简介:安蓬蓬(1979-),女,主治医师,硕士在读,研究方向:输血;
通信作者:汤华,E-mail:htang2002@yahoo.com。